Take Action: SGO Needs Your Help on Two Important Requests
Download the SGO Grassroots Advocacy Toolkit
Grassroots Talking Points (July 2025)
Take Action on FY 2026 Appropriations
The President’s fiscal year (FY) 2026 Budget Request proposes significant reductions in health funding and research, including the elimination and consolidation of some critical programs and activities. Specifically, the administration is proposing a 40 percent cut to the National Institutes of Health (NIH), a reorganization of the NIH’s 27 institutes and centers (ICs), and the relocation of the Centers for Disease Control and Prevention (CDC) National Center for Chronic Disease Prevention and Health Promotion programs.
The House is continuing to advance its appropriations bills; however, the Labor-HHS subcommittee markup is not expected to take place until after lawmakers return from August recess. The Senate will begin its work later this summer. Therefore, now is a critical time to reach out to your legislators to advocate for funding for gynecologic cancer research and care.
SGO needs your help! Please take action now by sending a message to your members of Congress urging them to support full and robust appropriations for gynecologic cancer research and care programs in FY 2026. This includes rejecting the administration’s proposed FY 2026 funding levels and preventing the reorganization of HHS agencies until Congressional and stakeholder feedback is considered.
Support Defense Health Research for Gynecologic Cancers
Before adjourning for the August recess, the House and Senate advanced their Fiscal Year (FY) 2026 Defense appropriations bills with approval by the full House and the Senate Appropriations Committee. Although both bills provided increases for the Congressionally Directed Medical Research Program (CDMRP), neither bill restored funding to the FY 2024 level of $1.5 million. SGO remains concerned that failure to restore or increase funding above that level would significantly disrupt research that spans basic biology through drug development, diagnostics, and clinical trials, including for gynecologic cancers. This research improves the health of our nation’s armed services, as well as veterans, military families, and the general public.
When Congress returns to Washington in September, they will have 28 days to finalize FY 2026 before the new fiscal year begins on October 1. The time is now to urge your members of Congress to provide robust funding for the CDMRP, including the Ovarian Cancer Research Program and the Peer Reviewed Cancer Research Program, which funds research on endometrial cancer.
Please take action now to protect high-impact research for gynecologic cancers!